Ms. Laura Lee Sandler's most recent trade in Oruka Therapeutics Inc. was a trade of 906 Common Stock done at an average price of $95.7 . Disclosure was reported to the exchange on Sept. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 95.71 per share. | 15 Sep 2026 | 906 | 235,478 | - | 95.7 | 86,713 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | 01 Sep 2026 | 5,000 | 74,996 | - | - | Employee Warrant (right to buy) | ||
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 01 Sep 2026 | 5,000 | 241,384 | - | 7.8 | 39,000 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 92.01 per share. | 01 Sep 2026 | 4,000 | 236,384 | - | 92.0 | 368,054 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 91.05 per share. | 01 Sep 2026 | 1,000 | 240,384 | - | 91.0 | 91,048 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 01 Jul 2026 | 5,000 | 241,384 | - | 7.8 | 39,000 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | 01 Jul 2026 | 5,000 | 79,996 | - | - | Employee Warrant (right to buy) | ||
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 94.75 per share. | 01 Jul 2026 | 2,263 | 236,884 | - | 94.7 | 214,410 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 93.85 per share. | 01 Jul 2026 | 2,237 | 239,147 | - | 93.8 | 209,933 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 95.47 per share. | 01 Jul 2026 | 500 | 236,384 | - | 95.5 | 47,736 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 69.69 per share. | 15 Jun 2026 | 600 | 236,384 | - | 69.7 | 41,814 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 01 May 2026 | 5,000 | 241,984 | - | 7.8 | 39,000 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | 01 May 2026 | 5,000 | 84,996 | - | - | Employee Warrant (right to buy) | ||
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 62.58 per share. | 01 May 2026 | 2,200 | 239,784 | - | 62.6 | 137,685 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 64.15 per share. | 01 May 2026 | 1,800 | 237,984 | - | 64.1 | 115,468 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 66.06 per share. | 01 May 2026 | 400 | 237,284 | - | 66.1 | 26,422 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 65.10 per share. | 01 May 2026 | 300 | 237,684 | - | 65.1 | 19,530 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 67.16 per share. | 01 May 2026 | 200 | 237,084 | - | 67.2 | 13,431 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 68.48 per share. | 01 May 2026 | 100 | 236,984 | - | 68.5 | 6,848 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 41.30 per share. | 16 Mar 2026 | 600 | 236,984 | - | 41.3 | 24,780 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 02 Mar 2026 | 5,000 | 242,584 | - | 7.8 | 39,000 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | 02 Mar 2026 | 5,000 | 89,996 | - | - | Employee Warrant (right to buy) | ||
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.81 per share. | 02 Mar 2026 | 2,675 | 237,584 | - | 33.8 | 90,436 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 33.28 per share. | 02 Mar 2026 | 2,325 | 240,259 | - | 33.3 | 77,386 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | 23 Jan 2026 | 130,000 | 130,000 | - | - | Employee Stock Option (right to buy) | ||
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2026 | 32,500 | 237,584 | - | 0 | Common Stock | |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 28.17 per share. | 02 Jan 2026 | 8,748 | 209,336 | - | 28.2 | 246,396 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.80 per share. | 02 Jan 2026 | 5,000 | 218,084 | - | 7.8 | 39,000 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | 02 Jan 2026 | 5,000 | 94,996 | - | - | Employee Warrant (right to buy) | ||
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 29.08 per share. | 02 Jan 2026 | 3,144 | 206,192 | - | 29.1 | 91,432 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 29.75 per share. | 02 Jan 2026 | 1,108 | 205,084 | - | 29.8 | 32,967 | Common Stock |
| Oruka Therapeutics Inc | Ms. Laura Lee Sandler | Chief Operating Officer | 01 Jul 2025 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) |